1351-0088 |
ENDOCRINE-RELATED CANCER |
CIÊNCIAS BIOLÓGICAS I |
A1 |
2017-2020 |
1871-5303 |
ENDOCRINE, METABOLIC AND IMMUNE DISORDERS. DRUG TARGETS |
CIÊNCIAS BIOLÓGICAS III |
B2 |
2017-2020 |
1871-5303 |
ENDOCRINE, METABOLIC AND IMMUNE DISORDERS. DRUG TARGETS |
CIÊNCIAS BIOLÓGICAS II |
B2 |
2017-2020 |
1871-5303 |
ENDOCRINE, METABOLIC AND IMMUNE DISORDERS. DRUG TARGETS |
CIÊNCIAS AMBIENTAIS |
B2 |
2017-2020 |
1871-5303 |
ENDOCRINE, METABOLIC AND IMMUNE DISORDERS. DRUG TARGETS |
CIÊNCIAS BIOLÓGICAS I |
B2 |
2017-2020 |
1871-5303 |
ENDOCRINE, METABOLIC AND IMMUNE DISORDERS. DRUG TARGETS |
MATERIAIS |
B2 |
2017-2020 |
1871-5303 |
ENDOCRINE, METABOLIC AND IMMUNE DISORDERS. DRUG TARGETS |
MEDICINA II |
B2 |
2017-2020 |
1871-5303 |
ENDOCRINE, METABOLIC AND IMMUNE DISORDERS. DRUG TARGETS |
MEDICINA I |
B2 |
2017-2020 |
1871-5303 |
ENDOCRINE, METABOLIC AND IMMUNE DISORDERS. DRUG TARGETS |
QUÍMICA |
B2 |
2017-2020 |
1871-5303 |
ENDOCRINE, METABOLIC AND IMMUNE DISORDERS. DRUG TARGETS |
CIÊNCIA DE ALIMENTOS |
B2 |
2017-2020 |
1871-5303 |
ENDOCRINE, METABOLIC AND IMMUNE DISORDERS. DRUG TARGETS |
BIOTECNOLOGIA |
B2 |
2017-2020 |
1871-5303 |
ENDOCRINE, METABOLIC AND IMMUNE DISORDERS. DRUG TARGETS |
FARMÁCIA |
B2 |
2017-2020 |
1871-5303 |
ENDOCRINE, METABOLIC AND IMMUNE DISORDERS. DRUG TARGETS |
SAÚDE COLETIVA |
B2 |
2017-2020 |
1871-5303 |
ENDOCRINE, METABOLIC AND IMMUNE DISORDERS. DRUG TARGETS |
INTERDISCIPLINAR |
B2 |
2017-2020 |
0163-769X |
ENDOCRINE REVIEWS |
INTERDISCIPLINAR |
A1 |
2017-2020 |